{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:24:19Z","timestamp":1720221859540},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2008.11.080","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T05:02:18Z","timestamp":1243486938000},"page":"A34-A38","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Sentinel Pap smears in 261 invasive cervical cancer patients in Italy"],"prefix":"10.1016","volume":"27","author":[{"given":"Sarah","family":"Igidbashian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Casadio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Boveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Cristoforoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Sideri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.11.080_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","article-title":"Estimates of the world-wide prevalence of cancer for 25 sites in the adult population","volume":"97","author":"Pisani","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2008.11.080_bib2","first-page":"701","article-title":"Cancer incidence and mortality trends among whites in the United States, 1947\u201384","volume":"79","author":"Devesa","year":"1987","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.vaccine.2008.11.080_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0959-8049(05)80359-4","article-title":"Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population","volume":"29A","author":"Aareleid","year":"1993","journal-title":"Eur J Cancer"},{"issue":"May (6941)","key":"10.1016\/j.vaccine.2008.11.080_bib4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/bmj.308.6941.1407","article-title":"Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease","volume":"308","author":"Macgregor","year":"1994","journal-title":"BMJ"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2008.11.080_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0020-7292(94)90177-5","article-title":"Pap smear screening and changes in cervical cancer mortality in Sweden","volume":"44","author":"Mahlck","year":"1994","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.vaccine.2008.11.080_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jms.9.2.86","article-title":"The cervical cancer screening programme in Norway, 1992\u20132000: changes in Pap smear coverage and incidence of cervical cancer","volume":"9","author":"Nygard","year":"2002","journal-title":"J Med Screen"},{"key":"10.1016\/j.vaccine.2008.11.080_bib7","unstructured":"Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER cancer statistics review, 1975\u20132000. Available at: <http:\/\/seer.cancer.gov\/csr\/1975_2000>; 2003."},{"issue":"May (9)","key":"10.1016\/j.vaccine.2008.11.080_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/jnci\/dji115","article-title":"Cervical cancer in women with comprehensive health care access: attributable factors in the screening process","volume":"97","author":"Leyden","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2008.11.080_bib9","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/ijc.22114","article-title":"Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands","volume":"119","author":"Bos","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2008.11.080_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2105\/AJPH.85.6.791","article-title":"The screening histories of women with invasive cervical cancer, Connecticut","volume":"85","author":"Janerich","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2008.11.080_bib11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00006254-199507000-00014","article-title":"Patterns of Pap smear screening in women diagnosed with invasive cervical cancer","volume":"50","author":"Hogenmiller","year":"1995","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.vaccine.2008.11.080_bib12","first-page":"152","article-title":"An epidemiologic study of Pap screening histories in women with invasive carcinomas of the uterine cervix","volume":"91","author":"Nasca","year":"1991","journal-title":"N Y State J Med"},{"key":"10.1016\/j.vaccine.2008.11.080_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/00016349609033339","article-title":"The cytological screening history of 469 patients with squamous cell carcinoma of the cervix uteri; does interval carcinoma exist?","volume":"75","author":"Kenter","year":"1996","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.vaccine.2008.11.080_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0002-9378(84)90774-9","article-title":"The cytologic history of 245 patients developing invasive cervical carcinoma","volume":"148","author":"Carmichael","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2008.11.080_bib15","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.0.CO;2-D","article-title":"Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan","volume":"88","author":"Sung","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2008.11.080_bib16","first-page":"513","article-title":"Review of the screening history of Alberta women with invasive cervical cancer","volume":"157","author":"Stuart","year":"1997","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2008.11.080_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1525-1438.1998.09795.x","article-title":"A registry-based study of follow-up failures in the screening experience of cervical cancer patients","volume":"8","author":"Amadori","year":"1998","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.vaccine.2008.11.080_bib18","first-page":"17","article-title":"Tumori in Italia\u2014Rapporto 2006. Incidenza, mortalit\u00e0 e stime","volume":"1","year":"2006","journal-title":"Epidemiologia e prevenzione"},{"key":"10.1016\/j.vaccine.2008.11.080_bib19","unstructured":"ISTAT. La prevenzione dei tumori femminili in Italia: il ricorso a Pap test e mammografia. Anni 2004\u20132005: 4 dicembre 2006."},{"issue":"April (8)","key":"10.1016\/j.vaccine.2008.11.080_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/bjc.1996.196","article-title":"Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer","volume":"73","author":"Sasieni","year":"1996","journal-title":"Br J Cancer"},{"issue":"December (99)","key":"10.1016\/j.vaccine.2008.11.080_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/cncr.11835","article-title":"Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening","author":"Mitchell","year":"2003","journal-title":"Cancer"},{"issue":"September (48)","key":"10.1016\/j.vaccine.2008.11.080_bib22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000326428","article-title":"Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case\u2013control study","author":"Mitchell","year":"2004","journal-title":"Acta Cytol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2008.11.080_bib23","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1158\/1055-9965.EPI-05-0231","article-title":"Incidence trends of adenocarcinoma of the cervix in 13 European countries","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2008.11.080_bib24","first-page":"1383","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"May (17)","key":"10.1016\/j.vaccine.2008.11.080_bib25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.281.17.1605","article-title":"Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results","volume":"281","author":"Manos","year":"1999","journal-title":"JAMA"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2008.11.080_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2008.11.080_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","article-title":"Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia","volume":"96","author":"Arbyn","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"November (11 Pt 1)","key":"10.1016\/j.vaccine.2008.11.080_bib28","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1158\/1055-9965.EPI-05-0151","article-title":"Evaluating the risk of cervical precancer with a combination of cytologic, virologic, and visual methods. 2005 Nov;14:2665-8","volume":"14","author":"Wang","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl. (3)","key":"10.1016\/j.vaccine.2008.11.080_bib29","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.vaccine.2006.05.122","article-title":"Chapter 10: new dimensions in cervical cancer screening","volume":"24","author":"Cuzick","year":"2006","journal-title":"Vaccine"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2008.11.080_bib30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1525-1438.2006.00462.x","article-title":"Prediction of high-grade cervical disease with human papillomavirus detection in women with glandular and squamous cytologic abnormalities","volume":"16","author":"de Oliveira","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2008.11.080_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.AOG.0000202401.29145.68","article-title":"Clinical significance of atypical glandular cells on cervical cytology","volume":"107","author":"Schnatz","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2008.11.080_bib32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/01.AOG.0000218705.87329.4a","article-title":"Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature","volume":"107","author":"DeSimone","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2008.11.080_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/01.AOG.0000153489.25288.c1","article-title":"Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology","volume":"105","author":"Sharpless","year":"2005","journal-title":"Obstet Gynecol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T03:57:25Z","timestamp":1545191845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08016368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":33,"alternative-id":["S0264410X08016368"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}